Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 231 to 240 of 2561

TitleReference numberPublishedLast updated
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)TA1032
Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumoursTA1034
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and overTA1031
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)TA1029
Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1030
Bimekizumab for treating moderate to severe hidradenitis suppurativa (terminated appraisal)TA1028
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanTA697
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 yearsNG247
Digitally enabled therapies for adults with depression: early value assessmentHTG675
Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessmentHTG739

Results per page

  1. 10
  2. 25
  3. 50
  4. All